Expect a lot of biotech papers authored by Chinese geniuses that are incomprehensible to anybody. None of the limitations on other high-tech fields (such as semiconductors) in China apply to biotech. In fact, they have some key advantages, like regional clinics that get hooked into public insurance & end up with gargantuan datasets. This will only get better as medicine is less centered around China’s east coast, but for the time being that bottleneck has some upsides too.